Individuals with dyslipidemia often develop type 2 diabetes, and diabetic patients often have dyslipidemia. It remains to be determined whether there are genetic connections between the 2 disorders. A female F 2 cohort, generated from BALB/cJ (BALB) and SM/J (SM) Apoe-deficient (Apoe −/− ) strains, was fed a Western diet for 12 weeks. Fasting plasma glucose and lipid levels were measured before and after Western diet feeding. 144 genetic markers across the entire genome were used for analysis. One significant QTL on chromosome 9, named Bglu17 [26.4 cM, logarithm of odds ratio (LOD): 5.4], and 3 suggestive QTLs were identified for fasting glucose levels. The suggestive QTL near the proximal end of chromosome 9 (2.4 cM, LOD: 3.12) was detected when mice were fed chow or Western diet and named Bglu16. Bglu17 coincided with a significant QTL for HDL and a suggestive QTL for non-HDL cholesterol levels. Plasma glucose levels were inversely correlated with HDL but positively correlated with non-HDL cholesterol levels in F 2 mice fed either diet. A significant correlation between fasting glucose and triglyceride levels was observed on the Western but not chow diet. Haplotype analysis revealed that "lipid genes" Sik3 and Apoc3 were probable candidates for Bglu17. We have identified multiple QTLs for fasting glucose and lipid levels. The colocalization of QTLs for both phenotypes and the sharing of potential causal genes suggest that dyslipidemia and type 2 diabetes are genetically connected.
Introduction
Individuals with dyslipidemia have an increased risk of developing type 2 diabetes (T2D), and diabetic patients often have dyslipidemia, which includes elevations in plasma triglyceride and LDL cholesterol levels and reductions in HDL cholesterol levels . Part of the increased diabetic risk associated with dyslipidemia is probably due to genetic variations that influence both lipoprotein homeostasis and the development of T2D. Indeed, a few rare gene mutations result in both dyslipidemia and T2D, including ABCA1 , and LRP6 ( M a n i e t a l . 2 0 0 7 )
. Genome-wide association studies (GWAS) have identified >150 loci associated with variation in plasma lipids . Over a dozen of the loci detected are associated with both lipid and T2D-related traits at the genome-wide significance level, including APOB, GCKR, TIMD4, LPA, HLA-B, MLXIPL, NPC1L1, CYP7A1, FADS1-2-3, LRP1, LACTB, CETP, APOE-C1-C2, TOP1, and PLTP (http://www.genome.gov/ GWAStudies/). Surprisingly, half of them, including CETP, MLXIPL, PLTP, GCKR, APOB, APOE-C1-C2, CYP7A1, and TIMD4, have shown opposite allelic effect on dyslipidemia and glucose levels , which is in contrary to the positive correlations observed at the clinical level. Furthermore, it is challenging to establish causality between genetic variants and complex traits in humans due to small gene effects, complex genetic structure, and environmental influences.
A complementary approach to finding genetic components in human disease is to use animal models. Apolipoprotein E-deficient (Apoe−/−) mice are a commonly used mouse model of dyslipidemia, with elevations in non-HDL cholesterol levels and reductions in HDL levels, even when fed a low fat chow diet . BALB/cJ (BALB) and SM/J Apoe−/− mice exhibit differences in dyslipidemia and T2D-related phenotypes . In the present study, we performed quantitative trait locus (QTL) analysis using a female cohort derived from an intercross between BALB-Apoe−/− and SM-Apoe−/− mice to explore potential genetic connections between dyslipidemia and T2D. 6
Methods
Mice: BALB and SM Apoe-/-mice were created using the classic congenic breeding strategy, as previously described
. BALB-Apoe-/-mice were crossed with SM-Apoe-/-mice to generate F1s, which were intercrossed by brother-sister mating to generate a female F2 cohort. . The expectation maximization (EM) algorithm was used to detect main effect loci for each trait. One thousand permutations of trait values were run to define the genome-wide LOD (logarithm of odds) score threshold needed for significant or suggestive linkage of each trait. Loci that exceeded the 95th percentile of the permutation distribution were defined as significant (P<0.05) and those exceeding the 37th percentile were suggestive (P<0.63).
Prioritization of positional candidate genes. The Sanger SNP database (http://www.sanger.ac.
uk/sanger/Mouse_SnpViewer/rel-1410) was used to prioritize candidate genes for overlapping QTLs affecting plasma glucose and HDL cholesterol levels on chromosome (Chr) 9, which were mapped in two or more crosses derived from different parental strains for either phenotype. We converted the original mapping positions in cM for the confidence interval to physical positions in Mb and then examined SNPs within the confidence interval. Probable candidate genes were defined as those with one or more SNPs in coding or upstream promoter regions that were shared by the parental strains carrying the "high" allele but were different from the parental strains carrying the "low" allele at a QTL, as previously reported . . The suggestive QTL on distal Chr5 (101.24 cM, LOD 3.198) was novel. The BALB allele conferred an increased glucose level for both of the Chr9 QTLs while the SM allele conferred increased glucose levels for the 2 Chr5 QTLs (Table   2) .
Results

Trait
Fasting lipid levels. Genome-wide scans for main effect QTLs showed that HDL, non-HDL cholesterol, and triglyceride levels were each controlled by multiple QTLs (Fig. 3 through 5, . For all 4 HDL QTLs, F2 mice homozygous for the SS allele had higher HDL levels than those homozygous for the BB allele (Table 2) .
For non-HDL cholesterol levels, 6 suggestive QTLs were detected when F2 mice were fed the chow diet, and 2 significant and 2 suggestive QTLs were detected on the Western diet ( Fig. 4) .
For triglyceride levels, 3 suggestive QTLs, located on Chr1, 2, and 5, respectively, were identified (Fig. 5 ). The Chr1 QTL peaked at 97 cM, 17 cM distal the Apoa2 gene (80 cM). The
Chr2 QTL replicated Tgq11, mapped in an intercross between DBA/1J and DBA/2J
. The Chr5 QTL was novel.
Coincident QTLs for fasting glucose and lipids. LOD score plots for Chr9 showed that the QTL for fasting glucose (Bglu17) coincided precisely with the QTLs for HDL (Hdlq17) and non-HDL (Nhdlq11) in the confidence interval ( Fig. 6 ). F2 mice homozygous for the BB allele exhibited elevated levels of fasting glucose and non-HDL but decreased levels of HDL, compared to those homozygous for the SS allele (Table 2) . These QTLs affected their respective trait values in an additive manner.
Correlations between plasma glucose and lipid levels. The correlations of fasting glucose levels with plasma levels of HDL, non-HDL cholesterol, or triglyceride were analyzed with the F2 population ( Fig. 7) . A significant inverse correlation between fasting glucose and HDL cholesterol levels was observed when the mice were fed a chow (R=-0.220; P=8. 1E-4) .
Discussion
BALB and SM are two mouse strains that exhibit distinct differences in HDL, non-HDL cholesterol, and type 2 diabetes-related traits when deficient in Apoe
. BALB-Apoe -/mice have higher HDL, lower non-HDL cholesterol, and lower glucose levels than SM-Apoe -/mice when fed a Western diet. To identify the genetic factors underlying these differences, we performed QTL analysis on a female cohort derived from an intercross between the two Apoe -/strains. We have identified four loci for fasting glucose levels, four loci for HDL cholesterol levels, nine loci for non-HDL cholesterol levels, and three loci for triglyceride levels.
Moreover, we have observed the colocalization of QTL for fasting glucose with the QTLs for HDL and non-HDL cholesterol on chromosome 9 and the sharing of potential candidate genes.
We identified a significant QTL near 26 cM on chromosome 9, which affected fasting plasma glucose levels of mice on either chow or Western diet. We named it Bglu17 to represent a novel locus regulating fasting glucose levels in the mouse. This locus is overlapping with a significant QTL (not named) for blood glucose levels on the intraperitoneal glucose tolerance test identified in a BKS.Cg-Leprdb+/+m x DBA/2 intercross and a suggestive QTL identified in a B6-Apoe -/x BALB-Apoe -/intercross . These "lipid genes" might also be the causal gene(s) of Bglu17, contributing to variation in fasting glucose levels. Although it is unknown how they affect glucose homeostasis, one probable pathway is through their action on plasma lipid levels, which then predispose variation in glucose-related traits. The current observation on the significant correlations of HDL, non-HDL cholesterol, and triglyceride levels with fasting glucose levels in this cross supports this speculation. Plasma lipid levels, especially non-HDL cholesterol, of the F2 mice were significantly elevated on the Western diet, so were the fasting glucose levels. When fed the Western diet, Apoe -/mice display a rapid rise in non-HDL cholesterol levels, often reaching a plateau within a couple of weeks (unpublished data), whereas their blood glucose levels rise more slowly and gradually within 12 weeks . A significant correlation of non-HDL cholesterol levels with fasting glucose levels was also observed in this cross, and the significance of correlation was extremely high when mice were fed the Western diet. Emerging human studies have also revealed associations of non-HDL cholesterol and ApoB with fasting glucose levels and incident type 2 diabetes . We previously observed that the elevation of non-HDL cholesterol levels in Apoe -/mice .
Plasma triglyceride levels were strongly correlated with fasting glucose levels in this cross on the Western diet, although no significant correlation was found when mice were fed the chow diet. Despite the strong correlation, no overlapping QTLs were found for fasting glucose and triglyceride. The reason for the discrepancy between non-HDL cholesterol and triglyceride in terms of the presence or absence of colocalized QTLs is unclear.
A suggestive QTL for fasting glucose near the proximal end of chromosome 9 (2.37 cM) was detected in this cross, initially on the chow diet and then replicated on the Western diet. The LOD score plot for chromosome 9 has shown 2 distinct peaks, one with a suggestive LOD score at the proximal end and one with a significant LOD score at a more distal region, suggesting the existence of two loci for fasting glucose on the chromosome. , also indicated the existence of two QTLs for the trait on chromosome 9. We named the proximal . However, the QTL (~90 cM) mapped in this study showed that it was more distal to the Apoa2 gene (80 cM), thus suggesting a different underlying causal gene.
In summary, we have identified multiple QTLs contributing to dyslipidemia and hyperglycemia in a segregating F2 population. Two green horizontal lines represent genome-wide significance thresholds for suggestive or 27 significant linkage (P=0.63 and P=0.05, respectively). Black plots reflect the LOD score calculated at 1-cM intervals, the red plot represents the effect of the BALB allele, and the blue plot represents the effect of the SM allele. If BALB represents the high allele, then the red plot will be to the right of the graph; otherwise, it will be to the left. 
